The availability of effective antiretroviral therapy has lowered the risk, and the severity, of neural sequelae of HIV infection. “Early in the HIV pandemic, approximately 15% of people with HIV had ...

One of the hot topics at this year's Conference on Retroviruses and Opportunistic Infections will be long COVID: potential causes, biomarkers, and the significance of viral rebound. A virologist ...

News reporting will resume with coverage of the Conference on Retroviruses and Opportunistic Infections (CROI), being held in San Francisco from 9 to 12 March. Our reporting team from CROI are Keith ...

As it does every year, the Conference on Retroviruses and Opportunistic Infections is shining a spotlight on emerging research in HIV over the course of 4 days, this year at the Colorado ...

By Apoorva Mandavilli Apoorva Mandavilli reported from the Conference on Retroviruses and Opportunistic Infections in Seattle. In people with advanced H.I.V. disease, the mpox virus — formerly k ...

The findings were presented at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver. On April 8, a research letter outlining the results of the blood study was published ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

presented at last week’s Conference on Retroviruses and Opportunistic Infections in Denver. “We’re concerned that this could be leading to, at least in part, some of the long COVID symptoms ...

Currently, Atea is focused on the clinical development of orally-available antiviral agents for difficult-to-treat, severe viral infections, including severe acute respiratory syndrome coronavirus ...

The data were presented at the Conference on Retroviruses and Opportunistic Infections (CROI) held February 19-22, 2023, in Seattle, Washington. The data were generated, in a clinical trial led by ...